B7-H4 (DD-O110) is overexpressed in high risk uterine endometrioid adenocarcinomas and inversely correlated with tumor T-cell infiltration

Gynecologic Oncology

Volumn 106, Issue 1, 2007, Pages 119-127

  Miyatake, Takashi ^a   Tringler, Barbara ^a   Liu, Wenhui ^b   Liu, Shu Hui ^b   Papkoff, Jackie ^b   Enomoto, Takayuki ^c   Torkko, Kathleen C ^a   Dehn, Donna L ^a   Swisher, Ashanta ^a   Shroyer, Kenneth R ^a  

^a UNIVERSITY OF COLORADO   (United States)

^b CFD Therapeutics Inc   (United States)

^c OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

B7 H4; biomarker; Endometrial carcinoma; Endometrioid cancer; immunohistochemistry; tumor immune surveillance

Indexed keywords

B7 H4 ANTIGEN; CD14 ANTIGEN; CD3 ANTIGEN; CD8 ANTIGEN; UNCLASSIFIED DRUG;

ADULT; ANTIGEN DETECTION; APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CANCER GROWTH; CANCER RISK; CELL INFILTRATION; CONTROLLED STUDY; ENDOMETRIUM CARCINOMA; ENDOMETRIUM CELL; ENDOMETRIUM HYPERPLASIA; FEMALE; GENE EXPRESSION; GENE LOCATION; GENE OVEREXPRESSION; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOSURVEILLANCE; LYMPHOCYTIC INFILTRATION; MACROPHAGE; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; STATISTICAL SIGNIFICANCE; T LYMPHOCYTE; TUMOR ASSOCIATED LEUKOCYTE;

ANTIGENS, CD80; APOPTOSIS; BLOTTING, WESTERN; CARCINOMA, ENDOMETRIOID; ENDOMETRIAL HYPERPLASIA; ENDOMETRIUM; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; LYMPHOCYTES, TUMOR-INFILTRATING; MACROPHAGES; MIDDLE AGED; NEOPLASM STAGING; OVARIAN NEOPLASMS; T-LYMPHOCYTES;

EID: 34250183451     PISSN: 00908258     EISSN: 10956859     Source Type: Journal    
DOI: 10.1016/j.ygyno.2007.03.039     Document Type: Article

References (35)

1. Levine D.A., and Hoskins W.J. Update in the management of endometrial cancer. Cancer J 8 Suppl 1 (2002) S31-S40
2. Lax S.F. Molecular genetic pathways in various types of endometrial carcinoma: from a phenotypical to a molecular-based classification. Virchows Arch 444 (2004) 213-223
3. Kurman R.J., Kaminski P.F., and Norris H.J. The behavior of endometrial hyperplasia. A long-term study of "untreated" hyperplasia in 170 patients. Cancer 56 (1985) 403-412
4. Sherman M.E., Bur M.E., and Kurman R.J. p53 in endometrial cancer and its putative precursors: evidence for diverse pathways of tumorigenesis. Human Pathol 26 (1995) 1268-1274
5. Kondratiev S., Sabo E., Yakirevich E., Lavie O., and Resnick M.B. Intratumoral CD8+ T lymphocytes as a prognostic factor of survival in endometrial carcinoma. Clin Cancer Res 10 (2004) 4450-4456
6. Morsi H.M., Leers M.P., Radespiel-Troger M., Bjorklund V., Kabarity H.E., Nap M., et al. Apoptosis, bcl-2 expression, and proliferation in benign and malignant endometrial epithelium: an approach using multiparameter flow cytometry. Gynecol Oncol 77 (2000) 11-17
7. Heatley M.K. A high apoptotic index occurs in subtypes of endometrial adenocarcinoma associated with a poor prognosis. Pathology 29 (1997) 272-275
8. Zang X., Loke P., Kim J., Murphy K., Waitz R., and Allison J.P. B7x: a widely expressed B7 family member that inhibits T cell activation. PNAS 100 (2003) 10388-10392
9. Choi I.H., Zhu G., Sica G.L., Strome S.E., Cheville J.C., Lau J.S., et al. Genomic organization and expression analysis of B7-H4, an immune inhibitory molecule of the B7 family. J Immunol 171 (2003) 4650-4654
10. Prasad D.V., Richards S., Mai X.M., and Dong C. B7S1, a novel B7 family member that negatively regulates T cell activation. Immunity 18 (2003) 863-873
11. Sica G.L., Choi I.H., Zhu G., Tamada K., Wang S.D., Tamura H., et al. B7-H4, a molecule of the B7 family, negatively regulates T cell immunity. Immunity 18 (2003) 849-861
12. Salceda S., Tang T., Kmet M., Munteanu A., Ghosh M., Macina R., et al. The immunomodulatory protein B7-H4 is overexpressed in breast and ovarian cancers and promotes epithelial cell transformation. Exp Cell Res 306 (2005) 128-141
13. Tringler B., Zhuo S., Pilkington G., Torkko K.C., Singh M., Lucia M.S., et al. B7-h4 is highly expressed in ductal and lobular breast cancer. Clin Cancer Res 11 (2005) 1842-1848
14. Tringler B., Liu W., Corral L., Torkko K.C., Enomoto T., Davidson S., et al. B7-H4 overexpression in ovarian tumors. Gynecol Oncol 100 (2006) 44-52
15. Miyatake T., and Shroyer K.R. Immunohistochemical validation of B7-H4 (DD-O110) as a biomarker of ovarian cancer: correlation with CA-125. In: Hayat M.A. (Ed). Immunohistochemistry of In Situ Hybridization of Human Carcinomas Vol. 4 (2006), Graphic World Publishing Services, St. Louis 499-503
16. Krambeck A.E., Thompson R.H., Dong H., Lohse C.M., Park E.S., Kuntz S.M., et al. B7-H4 expression in renal cell carcinoma and tumor vasculature: associations with cancer progression and survival. PNAS 103 (2006) 10391-10396
17. Sun Y., Wang Y., Zhao J., Gu M., Giscombe R., Lefvert A.K., et al. B7-H3 and B7-H4 expression in non-small-cell lung cancer. Lung Cancer 53 (2006) 143-151
18. Awadallah NS, Shroyer KR, Langer DA, Torkko KC, Chen YK, Bentz JS, et al. Detection of B7-H4 and p53 in pancreatic cancer: potential roles as cytologic diagnostic adjuncts. Unpublished data.
19. Ferguson A., Moore M., and Fox H. Expression of MHC products and leucocyte differentiation antigens in gynaecological neoplasms: an immunohistological analysis of the tumour cells and infiltrating leucocytes. Br J Cancer 52 (1985) 551-563
20. Ambros R.A., and Kurman R.J. Combined assessment of vascular and myometrial invasion as a model to predict prognosis in stage I endometrioid adenocarcinoma of the uterine corpus. Cancer 69 (1992) 1424-1431
21. Grabenbauer G.G., Lahmer G., Distel L., and Niedobitek G. Tumor-infiltrating cytotoxic T cells but not regulatory T-cells predict outcome in anal squamous cell carcinoma. Clin Cancer Res 12 (2006) 3355-3360
22. Finke J.H., Zea A.H., Stanley J., Longo D.L., Mizoguchi H., Tubbs R.R., et al. Loss of T-cell receptor zeta chain and p56lck in T-cells infiltrating human renal cell carcinoma. Cancer Res 53 (1993) 5613-5616
23. Matsuda M., Petersson M., Lenkei R., Taupin J.L., Magnusson I., Mellstedt H., et al. Alterations in the signal-transducing molecules of T cells and NK cells in colorectal tumor-infiltrating, gut mucosal and peripheral lymphocytes: correlation with the stage of the disease. Int J Cancer 61 (1995) 765-772
24. Wang Q., Stanley J., Kudoh S., Myles J., Kolenko V., Yi T., et al. T cells infiltrating non-Hodgkin's B cell lymphomas show altered tyrosine phosphorylation pattern even though T cell receptor/CD3-associated kinases are present. J Immunol 155 (1995) 1382-1392
25. Zea A.H., Curti B.D., Longo D.L., Alvord W.G., Strobl S.L., Mizoguchi H., et al. Alterations in T cell receptor and signal transduction molecules in melanoma patients. Clin Cancer Res 1 (1995) 1327-1335
26. Lai P., Rabinowich H., Crowley-Nowick P., Bell M.C., Mantovani G., and Whiteside T.L. Alterations in expression and function of signal-transducing proteins in tumor-associated T and natural killer cells in patients with ovarian carcinoma. Clin Cancer Res 2 (1996) 161-173
27. Shibuya T.Y., Nugyen N., McLaren C.E., Li K.T., Wei W.Z., Kim S., et al. Clinical significance of poor CD3 response in head and neck cancer. Clin Cancer Res 8 (2002) 745-751
28. Kryczek I., Zou L., Rodriguez P., Zhu G., Wei S., Mottram P., et al. B7-H4 expression identifies a novel suppressive macrophage population in human ovarian carcinoma. J Exp Med 203 (2006) 871-881
29. Isobe N., Onodera H., Mori A., Shimada Y., Yang W., Yasuda S., et al. Caspase-3 expression in human gastric carcinoma and its clinical significance. Oncology 66 (2004) 201-209
30. Nakagawara A., Nakamura Y., Ikeda H., Hiwasa T., Kuida K., Su M.S., et al. High levels of expression and nuclear localization of interleukin-1 beta converting enzyme (ICE) and CPP32 in favorable human neuroblastomas. Cancer Res 57 (1997) 4578-4584
31. Koomagi R., and Volm M. Relationship between the expression of caspase-3 and the clinical outcome of patients with non-small cell lung cancer. Anticancer Res 20 1B (2000) 493-496
32. Volm M., and Koomagi R. Prognostic relevance of c-Myc and caspase-3 for patients with non-small cell lung cancer. Oncol Rep 7 (2000) 95-98
33. Jonges L.E., Nagelkerke J.F., Ensink N.G., van der Velde E.A., Tollenaar R.A., Flueren G.J., et al. Caspase-3 activity as a prognostic factor in colorectal carcinoma. Lab Invest 81 (2001) 681-688
34. Peiro G., Diebold J., Baretton G.B., Kimmig R., and Lohrs U. Cellular apoptosis susceptibility gene expression in endometrial carcinoma: correlation with Bcl-2, Bax, and caspase-3 expression and outcome. Int J Gynecol Pathol 20 (2001) 359-367
35. Oudejans J.J., Harijadi A., Cillessen S.A., Busson P., Tan I.B., Dukers D.F., et al. Absence of caspase 3 activation in neoplastic cells of nasopharyngeal carcinoma biopsies predicts rapid fatal outcome. Mod Path 18 (2005) 877-885